Evidence map›Paper›PMID 24446442›Full record

ArticlePediatrics2014

2010 perinatal GBS prevention guideline and resource utilization.

Sagori Mukhopadhyay, Dmitry Dukhovny, Wenyang Mao, Eric C Eichenwald, Karen M Puopolo

Abstract read
In one paragraph

Article in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Implementation of the sepsis risk score for chorioamnionitis-exposed newborns.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Article
  13. What's the harm? Risks and benefits of evolving rule-out sepsis practices.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Review
  14. Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sagori MukhopadhyayDivision of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts;
Dmitry Dukhovny
Wenyang Mao
Eric C Eichenwald
Karen M Puopolo
Harvard University · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USThe University of Texas Health Science Center at Houston · US

Funding

Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
NCATS NIH HHS 8UL1TR000170-05NCATS NIH HHS UL1 TR000170
6 · The paper itself

Abstract

objectivesTo quantify differences in early-onset sepsis (EOS) evaluations, evaluation-associated resource utilization, and EOS cases detected, when comparing time periods before and after the implementation of an EOS algorithm based on the Centers for Disease Control and Prevention (CDC) 2010 guidelines for prevention of perinatal Group B Streptococcus (GBS) disease.

methodsRetrospective cohort study of infants born at ≥36 weeks' gestation from 2009 to 2012 in a single tertiary care center. One 12-month period during which EOS evaluations were based on the CDC 2002 guideline was compared with a second 12-month period during which EOS evaluations were based on the CDC 2010 guideline. A cost minimization analysis was performed to determine the EOS evaluation-associated costs and resources during each time period.

resultsDuring the study periods, among well-appearing infants ≥36 weeks' gestation, EOS evaluations for inadequate GBS prophylaxis decreased from 32/1000 to <1/1000 live births; EOS evaluation-associated costs decreased by $6994 per 1000 live births; and EOS evaluation-associated work hours decreased by 29 per 1000 live births. We found no increase in EOS evaluations for other indications, total NICU admissions, frequency of infants evaluated for symptoms before hospital discharge, or incidence of EOS during the 2 study periods.

conclusionsImplementation of an EOS algorithm based on CDC 2010 GBS guidelines resulted in a 25% decrease in EOS evaluations performed among well-appearing infants ≥36 weeks' gestation, attributable to decreased evaluation of infants born in the setting of inadequate indicated GBS prophylaxis. This resulted in significant changes in EOS evaluation-associated resource expenditures.

Indexed as

Streptococcus agalactiaeAlgorithmsCohort StudiesFemaleHealth ResourcesHumansInfant, NewbornMalePractice Guidelines as TopicRetrospective StudiesSepsisStreptococcal Infectionsearly-onset sepsisgroup B Streptococcusintrapartum antibiotic prophylaxisneonatal infection

Identifiers

PMID24446442
PMCPMC3904275
OpenAlexW2135935494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.